Skip to main content

Table 1 Mean age at diagnosis, by gender and age distribution for the complete cohort and2019 incident cases

From: Incidence and survival of transthyretin amyloid cardiomyopathy from a French nationwide study of in- and out-patient databases

Age at diagnosis

Complete cohort

2019 incident cases

All

Males

Females

All

Males

Females

Mean (SD)

78.7 (12.6)

78.6 (11.8)

78.9 (14.0)

81.9 (10.3)

81.6 (9.3)

82.4 (12.4)

Median

(Q1, Q3, IQR)

82.0

(73.5, 87.0, 13.5)

81.5

(73.5, 86.5, 13.0)

83.0

(73.5, 88.0, 14.5)

84.0

(78.0, 88.0, 10.0)

83.5

(77.5, 87.5, 10.0)

85.5

(79.0, 89.5, 10.5)

 < 50. n (%)

330 (3.7%)

176 (3.0%)

154 (5.1%)

35 (1.5%)

18 (1.1%)

17 (2.3%)

[50–59] n (%)

398 (4.4%)

254 (4.3%)

144 (4.8%)

51 (2.1%)

30 (1.8%)

21 (2.8%)

[60–69] n (%)

910 (10.2%)

609 (10.2%)

301 (10.1%)

147 (6.2%)

100 (6.1%)

47 (6.4%)

[70–79] n (%)

2,071 (23.1%)

1,530 (25.7%)

541 (18.1%)

486 (20.4%)

370 (22.6%)

116 (15.7%)

[80–89] n (%)

4,084 (45.6%)

2,760 (46.3%)

1,324 (44.2%)

1,265 (53.2%)

904 (55.1%)

361 (49.0%)

 ≥ 90. n (%)

1,157 (12.9%)

626 (10.5%)

531 (17.7%)

393 (16.5%)

218 (13.3%)

175 (23.7%)

n (%)

8,950

5,955 (66.5%)

2,995 (33.5%)

2,377

1,640 (69.0%)

737 (31.0%)

  1. SD: standard deviation. IQR: interquartile range